+91 8108605351
ops@medivervelabs.com

ABOUT US

We are specialize in the development and marketing of APIs and finished dosage pharmaceutical formulations. Our values transcend mere profits and guide us in fulfilling our responsibility towards society. This quest, for healing the world, drives our performance and helps us move towards.

RESEARCH & DEVELOPMENT

Integral to our operations, our manufacturing partners having R&D and bioequivalence centers. Our comprehensive R&D facility comprises of scientists and staff, who focus on the development of active pharmaceutical ingredients (APIs) and formulations, analytical development and bioequivalence studies. The state-of-the-art bioequivalence centre meets the growing needs of quality healthcare and drugs.

MANUFACTURING

We take pride in our robust manufacturing operations and quality standards with our world class manufacturing partners. We strive to meet these by focusing on achieving the highest benchmarks of hygiene, cleanliness and eliminating cross-contamination. Our manufacturing facilities are equipped to meet the mandatory prerequisites of Indian and various international regulatory bodies.

India business

Mediverve boasts an extensive portfolio of pharmaceutical products spanning various therapeutic areas, including Orthopaedic, Gynaecology, Paediatric, Gastroenterology, Neuropathy, pain management . This diverse range of medications caters to the needs of patients and healthcare providers worldwide, addressing critical health challenges and enhancing quality of life.

Mediverve has a presence in the Indian market and our products and services are highly appreciated by the patients and healthcare providers across the country.

With a field force of 50, a network of 5 Depot at Navi Mumbai, Patna, Muzaffarpur, Ranchi. 150+ stockists across Bihar, Jharkhand & Maharashtra. We believe in building brands and keep introducing new products to address the growing needs of our customers.

With each day we are evolving our products through Scientific research for extended therapeutic indications and expanding our presence to newer Geographies.